Medical Condition News

RSS

Study uncovers ancestry-specific genetic links to multiple sclerosis risk

A landmark study has uncovered novel ancestry-specific genetic variants linked to multiple sclerosis (MS), offering new insights that could reshape treatment approaches for diverse populations affected by the disease.

17 Sep 2024

Cancer patients favor early financial risk assessments

Patients with cancer want their care team to assess them early in treatment about their concerns related to costs of care, reports a Northwestern Medicine study.

17 Sep 2024

Telehealth app found to improve retention rates in opioid use disorder treatment

Patients who initiated treatment for opioid use disorder through a telehealth mobile app stayed with treatment at a greater rate over six months than those who started treatment in a physical clinic, a new study led by Oregon Health & Science University found.

17 Sep 2024

Socioeconomic disparities in coronary artery disease deaths linked to unhealthy behaviors

Lower socioeconomic status is associated with higher rates of death from coronary artery disease compared to higher socioeconomic status, and more than half of the disparities can be explained by four unhealthy behaviors.

17 Sep 2024

Large-scale study to explore impact of type 1 diabetes on brain development in children

About half of adults with type 1 diabetes face significant cognitive impairment, including problems with working memory and executive function that affect day-to-day thinking. But less is known about how the condition affects children during a window of time known to be critical for healthy brain development.

17 Sep 2024

Lupus Research Alliance announces 2024 Diversity in Lupus Research Award recipients

The Lupus Research Alliance (LRA) is pleased to announce the recipients of the 2024 Career Development and Postdoctoral Awards to Promote Diversity in Lupus Research.

17 Sep 2024

Assessing the impact of weight loss and blood sugar control in people with type 2 diabetes

A Cleveland Clinic research team has published the first study assessing the independent real-world impacts of weight loss and blood sugar control on clinical outcomes in people with type 2 diabetes treated with antidiabetic medications, and specifically with GLP-1RAs (the class of drug that includes Ozempic and Wegovy).

17 Sep 2024

Study identifies optimal meditation positions for ADHD patients

ADHD is a developmental condition of brain with symptoms such as inattention, hyperactivity or impulsivity.

17 Sep 2024

New $3.26 million grant launches Undiagnosed Diseases Network site in New York

A new four-year, $3.26 million grant from the National Institute of Neurological Disorders and Stroke (NINDS), a part of the National Institutes of Health (NIH), establishes the first Undiagnosed Diseases Network (UDN) site in the New York metropolitan area.

17 Sep 2024

Moderate coffee consumption linked to lower risk of multiple cardiometabolic diseases

Consuming moderate amounts of coffee and caffeine regularly may offer a protective effect against developing multiple cardiometabolic diseases, including type 2 diabetes, coronary heart disease and stroke, according to new research published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

17 Sep 2024

Microbial-immune interactions in severe asthma: Insights into pathogen dominance and treatment approaches

Researchers assess the airway microbiome and host immune-inflammatory responses to identify treatable aspects of severe asthma.

17 Sep 2024

Activation of PPARβ/δ-AMPK pathway shown to slow liver fibrosis development

A study led by Manuel Vázquez Carrera, group leader at the Diabetes and Associated Metabolic Diseases Networking Biomedical Research Centre (CIBERDEM) at the University of Barcelona, reveals advances in the understanding and treatment of liver fibrosis, a serious complication in the context of metabolic fatty liver disease, also known as MASLD (metabolic dysfunction-associated steatotic liver disease).

17 Sep 2024

Ohio State's novel DHODH inhibitor enters first human trials

A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the patient's bedside as part of a clinical trial.

17 Sep 2024

$4.1 million funding supports epilepsy treatment research using spider venom proteins

UQ researchers have received $4.1 million from the Medical Research Future Fund to advance their research into epilepsy treatments made from spider venom proteins.

17 Sep 2024

IBS symptoms improve with sugar and starch reduction

Bodil Ohlsson is a professor at Lund University and consultant at Skåne University Hospital. Her choice to investigate the role of sugars and starches in IBS is linked to a geneticist's discovery: a genetic variation that hinders the breakdown of sugars and starches in the gut is overrepresented among IBS patients.

17 Sep 2024

Intensive diabetes treatment improves periodontal health

Previous
1
...
61
62
63
64
65
66
67
...
5486
Next

Medical Condition News

Study uncovers ancestry-specific genetic links to multiple sclerosis risk

Cancer patients favor early financial risk assessments

Telehealth app found to improve retention rates in opioid use disorder treatment

Socioeconomic disparities in coronary artery disease deaths linked to unhealthy behaviors

Large-scale study to explore impact of type 1 diabetes on brain development in children

Lupus Research Alliance announces 2024 Diversity in Lupus Research Award recipients

Assessing the impact of weight loss and blood sugar control in people with type 2 diabetes

Study identifies optimal meditation positions for ADHD patients

New $3.26 million grant launches Undiagnosed Diseases Network site in New York

Moderate coffee consumption linked to lower risk of multiple cardiometabolic diseases

Microbial-immune interactions in severe asthma: Insights into pathogen dominance and treatment approaches

Activation of PPARβ/δ-AMPK pathway shown to slow liver fibrosis development

Ohio State's novel DHODH inhibitor enters first human trials

$4.1 million funding supports epilepsy treatment research using spider venom proteins

IBS symptoms improve with sugar and starch reduction

Intensive diabetes treatment improves periodontal health

Postsurgical treatment with pembrolizumab doubles cancer-free time for bladder cancer patients

Cancer patients face increased risk of long-term mental health problems

Semaglutide vs. liraglutide: One-year weight loss efficacy in obesity and type 2 diabetes

Iron deficiency linked to restless sleep in ADHD and autism

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News